Pathological Precision in pT1 CRC — Why PDCs Are Game-Changers for Clinical Risk Stratification

Background: The management of pT1 colorectal carcinoma (CRC) remains a significant challenge for clinical specialists. Decisions regarding conservative endoscopic therapy and radical surgical resection depend on the pathological identification of specific risk factors for lymph node metastasis (LNM). Historically, the subjectivity inherent in morphological assessment has led to substantial interobserver variability, affecting treatment plans for up to 30% of patients. Therefore, improving the reproducibility of these histological markers is essential to prevent both surgical overtreatment and the risk of overlooked nodal disease. Objective: To quantify interobserver variability among 20 experienced pathologists. Design: Retrospective, multicenter cohort study. Methods: This study is part of a population-based multicenter cohort study (EpiT1 consortium). Researchers focused on standardizing criteria for key features like tumor budding (TB) and invasion depth while evaluating the diagn more...